REQUEST A DEMO
Total
USD $0.00
Search more companies

Astellas Pharma Malaysia Sdn. Bhd. (Malaysia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Astellas Pharma Malaysia Sdn. Bhd. Profile Updated: August 31, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Astellas Pharma Malaysia Sdn. Bhd. is based in Malaysia. The head office is in Kuala Lumpur. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. It was first established on January 28, 2016. In its most recent financial highlights, the company reported a net sales revenue increase of 15.09% in 2023. Over the same period, its total assets grew by 7.68%. In 2023, Astellas Pharma Malaysia Sdn. Bhd.’s net profit margin decreased by 0.08%.

Headquarters
Suite 18.05, Level 18, Centrepoint North Tower, Mid Valley City, Lingkaran Syed Putra
Kuala Lumpur; Federal Territories; Postal Code: 59200

Contact Details: Purchase the Astellas Pharma Malaysia Sdn. Bhd. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Astellas Pharma Malaysia Sdn. Bhd. report to view the information.
Registered Capital:
Purchase the Astellas Pharma Malaysia Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Astellas Pharma Malaysia Sdn. Bhd. report to view the information.
Incorporation Date:
January 28, 2016
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Astellas Pharma Malaysia Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
15.09%
Total operating revenue
15.09%
Operating profit (EBIT)
20.53%
EBITDA
61.97%
Net Profit (Loss) for the Period
12.33%
Total assets
7.68%
Total equity
20.43%
Operating Profit Margin (ROS)
0.2%
Net Profit Margin
-0.08%
Return on Equity (ROE)
-1.22%
Quick Ratio
0.05%
Cash Ratio
-0.12%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?